检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:胡春梅[1] 李亚荣[1] 夏大文[1] 朱睿[2]
机构地区:[1]吉林大学第二医院肿瘤内科,长春130021 [2]吉林省医疗器械检验所,长春130021
出 处:《激光杂志》2005年第6期100-100,共1页Laser Journal
摘 要:目的:探讨CA系列及β-HCG联合检测在乳腺癌病情监测中的意义。方法;利用双抗体夹心法对84例乳腺癌患者进行CAl25、CAl53、CAl99、β-HCG的检测,并观察其在不同TNM分期及其不同病理水平的变化。结果:TNM临床分期越晚,4种肿瘤标志物水平越高;不同病理类型的患者之间4种肿瘤标志物水平无显著性差异:联合检测可提高病情评估的灵敏度。结论;该4种肿瘤标志物在乳腺癌病情监测方面可为临床提供有价值的资料。Objective: To study'the clinical significance of carcinoma associated antigen ( CA125, CA153, CA199 )and human chorionic gonadotropin(β - HCG)in evaluation of disease extent and nronitofing metastasis and recun^nce of breast cancer. Methods: These tumor markers in serum were measured in 84 patients with breast cancers, and change of the markers were observed in these patiynts with different stage and pathohistological evidence. Results:The later the stage of TNM of breast cancer, the higher levels of 4 tumor markers would be revealed. There was no significant difference in the levels of 4 tumor markers for patients with different pathohistological evidence. Combination of these tumor markers increased sensitivity of measurement. Conclusions : Measurement of CA125, CA153, CA199 and β-HCG in serum provided useful iinformation for evaluation of disease extent in patients with breast cancer.
关 键 词:乳腺癌 CA125 CA153 CA199 Β-HCG
分 类 号:TN248.1[电子电信—物理电子学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.171